Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Madrigal Pharmaceuticals (1MDGL.MI) Q2 2026 Earnings
1MDGL.MI
6
May
Confirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-4.42
-3.2
-1.98
-0.76
Details
Expected EPS
-3.599421087
Actual EPS
-2.7657499999999997
Surprise EPS
0.83
Surprise Percent
+23.16%
Description
Madrigal Pharmaceuticals (1MDGL.MI) has reported earnings of -2.7657499999999997 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login